Expanding role of T cells in acute kidney injury

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 1, 2014, Pages 9-16

  Kinsey, Gilbert R ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cisplatin; ischemia reperfusion; lymphocytes; natural killer T cell; Treg

Indexed keywords

ADENOSINE TRIPHOSPHATE; BEE VENOM; CISPLATIN; CREATININE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FINGOLIMOD; GRANZYME; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 35; PERFORIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL THERAPY; CREATININE BLOOD LEVEL; CYTOLOGY; CYTOTOXICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INNATE IMMUNITY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LIVER INJURY; LYMPHOCYTE FUNCTION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATOR RELEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; NATURAL KILLER T CELL; NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SPLEEN CELL; SPLENECTOMY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TISSUE INJURY; TISSUE REPAIR;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; IMMUNOTHERAPY; KIDNEY; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84890564243     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000436695.29173.de     Document Type: Review

References (79)

1. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380:756-766.
2. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002; 62:1539-1549.
3. Kaissling B, Le Hir M. The renal cortical interstitium: Morphological and functional aspects. Histochem Cell Biol 2008; 130:247-262.
4. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121:4210-4221.
5. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66:486-491.
6. Fiorina P, Ansari MJ, Jurewicz M, et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 2006; 17:716-723.
7. Lai LW, Yong KC, Igarashi S, Lien YH. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemiareperfusion injury. Kidney Int 2007; 71:1223-1231.
8. Li L, Huang L, Sung SS, et al. NKT cell activation mediates neutrophil IFNgamma production and renal ischemia-reperfusion injury. J Immunol 2007; 178:5899-5911.
9. Liu M, Chien CC, Burne-Taney M, et al. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 2006; 17:765-774.
10. Rabb H. Immune modulation of acute kidney injury. J Am Soc Nephrol 2006; 17:604-606.
11. Horie Y, Chervenak RP, Wolf R, et al. Lymphocytes mediate TNF-alphainduced endothelial cell adhesion molecule expression: Studies on SCID and RAG-1 mutant mice. J Immunol 1997; 159:5053-5062.
12. Kokura S, Wolf RE, Yoshikawa T, et al. T-lymphocyte-derived tumor necrosis factor exacerbates anoxia-reoxygenation-induced neutrophil-endothelial cell adhesion. Circ Res 2000; 86:205-213.
13. Le Moine O, Louis H, Demols A, et al. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 2000; 31:1266-1274.
14. Nikbakht-Sangari M, Qayumi AK, Keown PA. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemiareperfusion injury. Immunol Invest 2000; 29:13-26.
15. Zwacka RM, Zhang Y, Halldorson J, et al. CD4() T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100:279-289.
16. Takada M, Nadeau KC, Shaw GD, et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99:2682-2690.
17. Burne MJ, Daniels F, El Ghandour A, et al. Identification of the CD4() T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108:1283-1290.
18. Burne-Taney MJ, Liu M, Ascon D, et al. Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: A possible mechanism linking early injury and progressive renal disease Am J Physiol Renal Physiol 2006; 291:F981-F986.
19. Burne-Taney MJ, Yokota-Ikeda N, Rabb H. Effects of combined T-and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant 2005; 5:1186-1193.
20. Day YJ, Huang L, Ye H, et al. Renal ischemia-reperfusion injury and adenosine 2a receptor-mediated tissue protection: The role of CD4 T cells and IFN-gamma. J Immunol 2006; 176:3108-3114.
21. Ysebaert DK, De Greef KE, De Beuf A, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66:491-496.
22. Seino K, Motohashi S, Fujisawa T, et al. Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 2006; 97:807-812.
23. Li L, Huang L, Sung SS, et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 2008; 74:1526-1537.
24. Nelson PJ, Rees AJ, Griffin MD, et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012; 23:194-203.
25. Soos TJ, Sims TN, Barisoni L, et al. CX3CR1 interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 2006; 70:591-596.
26. Ascon DB, Ascon M, Satpute S, et al. Normal mouse kidneys contain activated and CD3CD4-CD8-double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol 2008; 84:1400-1409.
27. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109:e102-e107.
28. Rosin DL, Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 2011; 22:416-425.
29. Dong X, Swaminathan S, Bachman LA, et al. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int 2005; 68:1096-1108.
30. Dong X, Swaminathan S, Bachman LA, et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007; 71:619-628.
31. Li L, Okusa MD. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol 2010; 30:268-277.
32. Kelly KJ, WilliamsWWJr, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97:1056-1063.
33. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFNgamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120:331-342.
34. Okusa MD, Linden J, Huang L, et al. A(2a) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 2000; 279:F809-F818.
35. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013; 13:227-242.
36. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002; 61:855-861.
37. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2006; 6:849-858.
38. Kania G, Siegert S, Behnke S, et al. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation 2013; 127:2285-2294.
39. Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22:317-326.
40. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4-12.
41. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532.
42. Fontenot JD, Gavin MA, Rudensky AY. FoxP3 programs the development and function of CD4CD25 regulatory T cells. Nat Immunol 2003; 4:330-336.
43. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science 2003; 299:1057-1061.
44. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for scurfin in CD4CD25 T regulatory cells. Nat Immunol 2003; 4:337-342.
45. Godfrey DI, Kronenberg M. Going both ways: Immune regulation via CD1ddependent NKT cells. J Clin Invest 2004; 114:1379-1388.
46. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol 2010; 11:197-206.
47. Ko GJ, Jang HR, Huang Y, et al. Blocking fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol 2011; 22:732-742.
48. Akcay A, Nguyen Q, He Z, et al. IL-33 exacerbates acute kidney injury. J Am Soc Nephrol 2011; 22:2057-2067.
49. Yokota N, Burne-Taney M, Racusen L, Rabb H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003; 285:F319-F325.
50. Bajwa A, Huang L, Ye H, et al. Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol 2012; 189:2584-2596. This article shows that the context in which type I NKT cells are activated in vivo with their ligand a-galactosylceramide can determine whether AKI is exacerbated or inhibited. S1PR3-deficient dendritic cells activate NKT cells in such a way that a Th2 response is predominant and this is protective against kidney IRI.
51. Yang SH, Lee JP, Jang HR, et al. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol 2011; 22:1305-1314.
52. Yokote H, Miyake S, Croxford JL, et al. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008; 173:1714-1723.
53. Gangadharan C, Thoh M, Manna SK. Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL. Breast Cancer Res Treat 2010; 120:671-683.
54. Nozaki Y, Nikolic-Paterson DJ, Yagita H, et al. Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2011; 301:F1098-F1104.
55. Rong S, Park JK, Kirsch T, et al. The TIM-1: YIM-4 pathway enhances renal ischemia-reperfusion injury. J Am Soc Nephrol 2011; 22:484-495.
56. Ichimura T, Brooks CR, Bonventre JV. Kim-1/Tim-1 and immune cells: Shifting sands. Kidney Int 2012; 81:809-811. This editorial gives a nice summary of what is known about KIM-1/TIM-1 on renal cells, T cells and other immune cells and their potential roles in AKI. It also explains the caveats of several reagents used to investigate the KIM-1/TIM-1 pathway.
57. Bodor J, Bopp T, Vaeth M, et al. Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 2012; 42:1375-1384.
58. Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753.
59. Gandolfo MT, Jang HR, Bagnasco SM, et al. FoxP3() regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009; 76:717-729.
60. Monteiro RMM, Camara NOS, Rodrigues MM, et al. A role for regulatory T cells in renal acute kidney injury. Transpl Immunol 2009; 21:50-55.
61. Cho WY, Choi HM, Lee SY, et al. The role of Tregs and CD11c() macrophages/dendritic cells in ischemic preconditioning of the kidney. Kidney Int 2010; 78:981-992.
62. Kinsey GR, Huang L, Vergis AL, et al. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 2010; 77:771-780.
63. Lee H, Nho D, Chung HS, et al. CD4CD25 regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int 2010; 78:1100-1109.
64. Kinsey GR, Huang L, Jaworska K, et al. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 2012; 23:1528-1537. This work shows that in order to protect the kidney from IRI, Tregs must generate their own adenosine, via CD73, which acts on Treg A2ARs to promote PD-1 expression on the cell surface of Tregs. Ex-vivo activation of the A2AR enhances the ability of Tregs to suppress kidney IRI in a PD-1-dependent manner.
65. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 2011; 117:1061-1070.
66. Di Ianni M, Falzetti F, Carotti A, et al. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. Best Pract Res Clin Haematol 2011; 24:459-466.
67. Marek-Trzonkowska N, Mysliwiec M, Dobyszuk A, et al. Administration of CD4CD25highCD127-regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 2012; 35:1817-1820.
68. Lai L-W, Yong K-C, Lien Y-HH. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int 2012; 81:983-992. In this article, the authors show that administration of DMS rapidly promotes Treg trafficking to the postischemic kidney and reduces injury. The protective effect is inhibited if Tregs are partially depleted or if CTLA-4 blocking antibodies are administered.
69. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over FoxP3 regulatory T cell function. Science 2008; 322:271-275.
70. Kim M-G, Lee SY, Ko YS, et al. CD4 CD25 regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2011; 26:111-124.
71. Bee venom is shown to induce expansion of Tregs in vivo and promote early trafficking of Tregs into the kidney after cisplatin administration. Bee venom mitigated cisplatin-induced renal injury in a Treg-dependent manner but did not affect cisplatin's ability to retard tumor growth in vivo.
72. Webster KE, Walters S, Kohler RE, et al. In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to eae and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009; 206:751-760. 73.
73. Kim MG, Koo TY, Yan JJ, et al. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol 2013; 24:1529-1536. IL-2/anti-IL-2 complexes cause Treg expansion in the spleen and kidney and when given prior to IRI protect against kidney injury. Importantly, when IL-2/anti-IL-2 complexes are given 24 h after IRI they promote functional recovery and inhibit renal fibrosis
74. Hu J, Zhang L, Wang N, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int 2013; 84:521-531. The protective effect of MSC administration in a mouse model of AKI is shown to partially depend on their interaction with Tregs inside the spleen of the recipient. Splenectomy or Treg depletion inhibits the protective ability of MSCs.
75. Li L, Huang L, Ye H, et al. Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury. J Clin Invest 2012; 122:3931-3942. The presence of an A2AR agonist at the time that dendritic cells are loaded with the type I NKT cell antigen a-galactosylceramide endows these dendritic cells with the ability to protect against kidney IRI even when given up to 6 h after ischemia. Adoptive transfer of these anti-inflammatory dendritic cells promotes IL-10 production in the recipient, which is required for the observed protection.
76. Mantia-Smaldone GM, Chu CS. A review of dendritic cell therapy for cancer: Progress and challenges. BioDrugs 2013; 27:453-468.
77. Patschan D, Krupincza K, Patschan S, et al. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: Modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006; 291:F176-F185.
78. Andres-Hernando A, Altmann C, Ahuja N, et al. Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. Am J Physiol Renal Physiol 2011; 301:F907-F916.
79. Gigliotti JC, Huang L, Ye H, et al. Ultrasound prevents renal ischemiareperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol 2013; 24:1451-1460.